Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells

SIMPLE SUMMARY: Human natural killer (NK) cells can be targeted to tumor antigens by their IgG Fc receptors that interact with the Fc regions of antibodies that recognize surface proteins on cancer cells. Therapeutic antibodies specific to cancer cell antigens are used to treat various malignancies....

Descripción completa

Detalles Bibliográficos
Autores principales: Dixon, Kate J., Wu, Jianming, Walcheck, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829765/
https://www.ncbi.nlm.nih.gov/pubmed/33467027
http://dx.doi.org/10.3390/cancers13020312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829765/
https://www.ncbi.nlm.nih.gov/pubmed/33467027
http://dx.doi.org/10.3390/cancers13020312

Ejemplares similares